COYA

Coya Therapeutics, Inc.

A Houston-based biotech developing therapies that boost the body's regulatory T cells — the immune system's peacekeepers — to fight the inflammation behind neurodegenerative diseases like Parkinson's, Alzheimer's and ALS. Founder Dr. Howard Berman started the company in 2020 after his father's battle with dementia, teaming up with neurologist Dr. Stanley Appel. Its name echoes the earlier venture Berman co-founded, Nicoya Health.